US2016052974A1PendingUtilityA1
Novel genes and proteins of brachyspira hyodysenteriae and uses thereof
Est. expiryAug 3, 2027(~1.1 yrs left)· nominal 20-yr term from priority
C07K 14/20G01N 33/56911A61P 37/04A61K 39/0225A61P 31/04A61K 2039/552G01N 2333/20
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Novel polynucleotide and amino acids of Brachyspira hyodysenteriae are described. These sequences are useful for diagnosis of B. hyodysenteriae disease in animals and as a therapeutic treatment or prophylactic treatment of B. hyodysenteriae disease in animals. These sequences may also be useful for diagnostic and therapeutic and/or prophylactic treatment of diseases in animals caused by other Brachyspira species, including B. intermedia, B. suantatina, B. alvinipulli, B. aalborgi, B. innocens, B. murdochii , and B. pilosicoli.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide comprising the full length of an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 with a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
2 - 5 . (canceled)
6 . An immunogenic composition comprising the polypeptide of claim 1 .
7 - 30 . (canceled)
31 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 1 .
32 - 44 . (canceled)
45 . An isolated polypeptide comprising a sequence that is at least 70% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
46 . An isolated polypeptide comprising a sequence that is at least 80% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
47 . An isolated polypeptide comprising a sequence that is at least 90% homologous to a polypeptide with an amino acid sequence selected from the group consisting of SEQ ID NO: 22, 32, and 64 and a heterologous polypeptide that permits the detection, isolation, solubilization, or stabilization of the isolated polypeptide.
48 . An immunogenic composition comprising the polypeptide of claim 45 .
49 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 45 .
50 . An immunogenic composition comprising the polypeptide of claim 46 .
51 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 46 .
52 . An immunogenic composition comprising the polypeptide of claim 47 .
53 . A method of generating an immune response to Brachyspira infection in an animal comprising administering to said animal the polypeptide of claim 47 .Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.